Release Date: 24/03/10 16:42 Summary: Proposed Shareholder Resolutions Price Sensitive: No Download Document 27.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%